Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Open Label Study Comparing the Impact of Reducing the Dose of Stavudine Versus Switching to Tenofovir on Plasma Lipids, Body Composition and Mitochondrial Function in HIV-Infected Patients Receiving Antiretroviral Therapy

NCT00312832 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00312832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Open Label Study Comparing the Impact of Reducing the Dose of Stavudine Versus Switching to Tenofovir on Plasma Lipids, Body Composition and Mitochondrial Function in HIV-Infected Patients Receiving Antiretroviral Therapy
Lead sponsor
Hospital Clinic of Barcelona
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2004
Completion date
February 28, 2005
Enrollment
60
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, lipoatrophy